scispace - formally typeset
M

Mark Lewandoski

Researcher at National Institutes of Health

Publications -  70
Citations -  9607

Mark Lewandoski is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Paraxial mesoderm & Somitogenesis. The author has an hindex of 36, co-authored 66 publications receiving 8962 citations. Previous affiliations of Mark Lewandoski include University of California, San Francisco.

Papers
More filters
Journal ArticleDOI

Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice

TL;DR: The mouse gene for mitochondrial transcription factor A (Tfam), formerly known as m-mtTFA, is disrupted by gene targetting of loxP-sites followed by cre-mediated excision in vivo and is the first mammalian protein demonstrated to regulate mtDNA copy number in vivo.
Journal ArticleDOI

An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination.

TL;DR: Analysis of embryos carrying different combinations of these alleles revealed requirements for Fgf8 gene function during gastrulation, as well as cardiac, craniofacial, forebrain, midbrain and cerebellar development.
Journal ArticleDOI

Conditional control of gene expression in the mouse

TL;DR: Here, I review binary systems used to analyse complex and multi-staged biological processes, such as embryogenesis and cancer, with unprecedented precision and discuss certain studies that exemplify the advantages and limitations of each system.
Journal ArticleDOI

Targeted disruption of Fgf8 causes failure of cell migration in the gastrulating mouse embryo

TL;DR: Fgf8 is identified as a gene essential for gastrulation and shows that signaling via FGF8 and/or FGF4 is required for cell migration away from the primitive streak of the gastrulating mouse embryo.
Journal ArticleDOI

Fgf8 signalling from the AER is essential for normal limb development.

TL;DR: It is reported here that inactivating F gf8 in early limb ectoderm causes a substantial reduction in limb-bud size, a delay in Shh expression, misregulation of Fgf4 expression, and hypoplasia or aplasia of specific skeletal elements.